Published in Princess Takamatsu Symp on January 01, 1989
Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77
Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. J Biol Chem (2003) 1.31
E7 abolishes raf-induced arrest via mislocalization of p21(Cip1). Mol Cell Biol (2002) 1.09
Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses? J Mammary Gland Biol Neoplasia (2009) 1.00
DNA virus replication compartments. J Virol (2013) 0.94
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. Mol Vis (2008) 0.90
Targeting tumor suppressor networks for cancer therapeutics. Curr Drug Targets (2014) 0.87
Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus. J Virol (1992) 0.83
Immortalized cells as experimental models to study cancer. Cytotechnology (2004) 0.79
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53
New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med (1992) 5.51
Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70
Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell (1989) 3.08
Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02
The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99
The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98
Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80
Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev (1996) 2.71
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60
Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells. J Virol (1981) 2.60
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Nuclear organization of DNA replication in primary mammalian cells. Genes Dev (2000) 2.48
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol (1997) 2.33
Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv (1992) 2.29
Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol (1986) 2.27
Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene (1993) 2.20
Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol (1991) 2.20
Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev (1998) 2.14
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol (2001) 2.14
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09
Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell (1998) 2.02
In vivo association of E2F and DP family proteins. Mol Cell Biol (1995) 1.99
Cellular proteins reactive with monoclonal antibodies directed against simian virus 40 T-antigen. J Virol (1982) 1.90
Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene (1991) 1.84
Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci (1996) 1.84
Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol (1993) 1.75
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73
Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci U S A (1996) 1.72
A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr Biol (1999) 1.70
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J (1994) 1.67
SV40 T antigen binds specifically to a cellular 53 K protein in vitro. Nature (1981) 1.62
Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol (1996) 1.62
Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J (1987) 1.61
Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol (1997) 1.61
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet (1993) 1.59
Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc Natl Acad Sci U S A (2000) 1.59
Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J Virol (1992) 1.54
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res (2001) 1.51
Retinoblastoma. For our eyes only. Nature (1992) 1.50
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci U S A (1997) 1.47
Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Mol Cell Biol (1993) 1.47
A large-scale overexpression screen in Saccharomyces cerevisiae identifies previously uncharacterized cell cycle genes. Proc Natl Acad Sci U S A (2001) 1.45
Opposing roles of pRB and p107 in adipocyte differentiation. Proc Natl Acad Sci U S A (2000) 1.43
The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol (1992) 1.40
Pterygium in Australia: a cost of illness study. Clin Experiment Ophthalmol (2001) 1.40
Cloning and expression of a mammalian peptide chain release factor with sequence similarity to tryptophanyl-tRNA synthetases. Proc Natl Acad Sci U S A (1990) 1.38
Tumour-suppressor genes: evolving definitions in the genomic age. Nat Genet (1997) 1.33
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J Virol (1993) 1.29
Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J Virol (1991) 1.25
Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health. Minerva Pediatr (2007) 1.22
Adenovirus E1A is associated with a serine/threonine protein kinase. J Virol (1991) 1.19
Cell cycle regulation of histone H1 kinase activity associated with the adenoviral protein E1A. Science (1991) 1.19
Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J Gen Virol (1993) 1.19
Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J Virol (1994) 1.18